Skip to main content

Acupuncture Reduces Endocrine Symptoms, Hot Flashes in Breast Cancer

Medically reviewed by Carmen Pope, BPharm. Last updated on June 24, 2024.

By Elana Gotkine HealthDay Reporter

MONDAY, June 24, 2024 -- A 10-week acupuncture intervention significant reduces endocrine symptoms and hot flashes among women with breast cancer receiving endocrine therapy (ET), according to a study published online June 24 in Cancer.

Weidong Lu, M.P.H., Ph.D., from the Dana Farber Cancer Institute in Boston, and colleagues enrolled 158 patients with stage 0 to III breast cancer who were receiving ET and experiencing hot flashes through three parallel, randomized trials in the United States, China, and South Korea (78, 40, and 40 patients, respectively). Participants were randomly allocated to receive immediate acupuncture (IA), which comprised 20 sessions over 10 weeks, or delayed acupuncture control (DAC), whereby participants received usual care then crossed over to reduced intensity acupuncture.

The researchers found that compared with DAC participants, IA participants reported significant improvements in the endocrine symptom subscale score, the hot flash score, and the Functional Assessment of Cancer Therapy-Breast total score at 10 weeks. The effect of the acupuncture intervention varied by site.

"Additional trials are needed to evaluate the effect of acupuncture on hot flashes in more racially and ethnically diverse populations of patients with breast cancer and to determine whether improvements in hot flashes translate into better medication adherence, increasing the likelihood that acupuncture not only could help patients feel better during ET but also may help to improve cancer‐related outcomes in women with breast cancer," the authors write.

Abstract/Full Text (subscription or payment may be required)

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2024 HealthDay. All rights reserved.

Posted June 2024

Read this next

Study Quantifies Risk for Gastric, Breast Cancer for Germline CDH1 P/LP Variants

FRIDAY, June 21, 2024 -- The cumulative risk for advanced gastric cancer varies from 6.5 to 10.3 percent for carriers of germline CDH1 pathogenic/likely pathogenic (P/LP)...

Chronic Kidney Disease Tied to Tooth Loss After Menopause

MONDAY, June 17, 2024 -- In postmenopausal women, chronic kidney disease (CKD) may be associated with tooth loss, according to a study published online June 11...

Neighborhood Deprivation Only Tied to Breast Cancer Mortality for White Women

FRIDAY, June 14, 2024 -- Factors aside from neighborhood deprivation are responsible for increased breast cancer mortality among Black women, according to a study published online...

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.